Carrillo J A, Benítez J
Departamento de Farmacología y Psiquiatría, Facultad de Medicina, Universidad de Extremadura, Badajoz, Spain.
Clin Pharmacol Ther. 1994 Mar;55(3):293-304. doi: 10.1038/clpt.1994.30.
We studied the oxidative and N-acetylator caffeine metabolic profile in 107 healthy Spanish volunteers. Smokers had significantly higher N-1- and N-3-demethylations activities than nonsmokers (p = 0.03 and p = 0.02, respectively), and the three caffeine demethylations indexes were strongly correlated with each other (r > 0.7; p < 0.001). Our in vivo studies suggest that CYP1A2 is involved, at least in part, in the primary N-demethylations of caffeine. A non-normal and possibly bimodal distribution was detected in the xanthine oxidase activity (p = 0.04), with about 4% of subjects deficient of this metabolic activity. The population exhibited a trimodal distribution of acetylator phenotype determined by use of the 5-acetylamino-6-amino-3-methyluracil/1-methylxanthine ratio (normality test; p = 0.004). Seventy subjects (65.4%) were phenotyped as slow acetylators. The mutated gene frequency was 0.81, which is similar to other white populations.
我们研究了107名健康西班牙志愿者的咖啡因氧化代谢和N-乙酰化代谢情况。吸烟者的N-1-去甲基化和N-3-去甲基化活性显著高于不吸烟者(分别为p = 0.03和p = 0.02),且三种咖啡因去甲基化指标彼此之间高度相关(r > 0.7;p < 0.001)。我们的体内研究表明,CYP1A2至少部分参与了咖啡因的初级N-去甲基化过程。在黄嘌呤氧化酶活性方面检测到非正态且可能为双峰分布(p = 0.04),约4%的受试者缺乏这种代谢活性。通过使用5-乙酰氨基-6-氨基-3-甲基尿嘧啶/1-甲基黄嘌呤比值确定的乙酰化表型在该人群中呈现三峰分布(正态性检验;p = 0.004)。70名受试者(65.4%)被表型鉴定为慢乙酰化者。突变基因频率为0.81,与其他白种人群相似。